Connacht Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$280K	Buy	8,204 +2,039	+33%	+$69.7K	1.66%	33
2023 Q2	$237K	Sell	6,165 -226	-4%	-$8.7K	0.32%	58
2023 Q1	$229K	Buy	+6,391	New	+$229K	0.1%	69